Ellagic acid nanoliposomes potentiate therapeutic effects of PEGylated liposomal doxorubicin in melanoma: An in vitro and in vivo study
Fatemeh HeidarianDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranSeyedeh Hoda AlavizadehDepartment of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranMahmoud Reza KalantariDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranSeyed Javad HoseiniDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranHelaleh Kaboli FarshchiNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, IranMahmoud Reza JaafariDepartment of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranMaham DoagooyanDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranAbolfazl BemidinezhadDepartment of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranPrashant KesharwaniDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, IndiaAmirhossein SahebkarApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, IranFatemeh GheybiDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2024en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references